Search results
Johnson & Johnson to acquire Proteologix for $850 million
New Hampshire Union Leader· 13 hours agoJohnson & Johnson said it would acquire Proteologix for $850 million as it looks to gain access to...
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga via Yahoo Finance· 7 hours agoThursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 10 hours agoA month has gone by since the last earnings report for Johnson & Johnson (JNJ). Shares have added...
Analyst Report: Johnson & Johnson
Morningstar Research via Yahoo Finance· 9 hours agoJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics ...
Johnson & Johnson Executive Urges US to Protect Research Credit
Bloomberg Law· 2 hours agoThe US government should work to protect its research and development credit by negotiating better treatment in the 15% global minimum tax rules, a top executive for Johnson & Johnson said Thursday.
Evergreen Wealth Solutions LLC Sells 689 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoEvergreen Wealth Solutions LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 10.0% during the fourth quarter, according to the company ...
Q3 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Cut by Analyst
ETF DAILY NEWS· 7 days agoJohnson & Johnson (NYSE:JNJ – Free Report) – Investment analysts at Zacks Research lowered their Q3 2024 earnings estimates for shares of Johnson ...
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 3 days agoJohnson & Johnson (JNJ Quick QuoteJNJ - Free Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Large Cap Pharmaceuticals ...
Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio
Morningstar· 13 hours agoJohnson & Johnson has agreed to buy privately-held biotechnology company Proteologix for an initial $850 million in cash in a deal that bolsters the healthcare ...
E Fund Management Co. Ltd. Increases Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoE Fund Management Co. Ltd. grew its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 10.5% during the 4th quarter, according to the company ...